A cholecystokinin receptor antagonist blocks milk-induced but not maternal-contact-induced decrease of ultrasonic vocalization in rat pups.
The role of cholecystokinin (CCK) in reducing separation-induced ultrasonic vocalization (USV) was examined by peripheral administration (of the selective CCK(A) receptor antagonist devazepide to 10-11-day-old rats. Pups placed alone for 2 min emitted a mean of 55.1 USV/min. When placed on a paper towel wet with warm, sweet milk, USV rate decreased to 23.2/min for the following 8 min. Devazepide (150-600 microg/kg IP) prevented this USV reduction, but did not increase feeding. In contrast, USV reduction produced by contact with the anesthetized dam was not affected by devazepide. Similarly, the opiate antagonist naltrexone (0.5 and 1.0 mg/kg) has been shown to block morphine-induced USV decrease in pups away from the dam, but was ineffective when USV reduction was induced by the presence of the dam (Blass et al., 1990; Carden & Hofer, 1990). The current findings suggest that CCK's role is specific, in that it mediates milk- but not dam-induced quieting of USV. The results, however, are not incompatible with the possibility that CCK and opioids are part of multiple, redundant pathways that mediate the quieting of USV by the dam.
Weller
A
A
Department of Psychology, Bar Ilan University, Ramat Gan, Israel. weller@mail.biu.ac.il
Gispan
I H
IH
D000818:Animals; D002766:Cholecystokinin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003259:Consummatory Behavior / Q000187:drug effects; D020109:Devazepide / Q000378:metabolism*; D005260:Female; D008297:Male; D008425:Maternal Behavior; D051381:Rats; D017207:Rats, Sprague-Dawley / Q000254:growth & development / Q000502:physiology*; D014828:Vocalization, Animal
D002766:Cholecystokinin; D020109:Devazepide